The efficacy of palbociclib/palbociclib/palbociclib

Palbociclib is a cyclin-dependent kinase4/6 inhibitor, used in combination with aromatase inhibitors Initial treatment of hormone receptor-positive, human epidermal growth factor receptor type 2 (HER2)-negative advanced or metastatic breast cancer in postmenopausal women or men. In combination with fulvestrant for the treatment of patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer whose disease has progressed after endocrine therapy.

Palbocicillin has been studied in two major studies in women with HRpositive, HER2negative breast cancer. In both studies, the main measure of effectiveness was how long patients lived without their disease getting worse (progression-free survival).

The first study involved521 women with metastatic breast cancer whose disease worsened after receiving hormone medication. They received either palbocicillin and fulvestrant or placebo(dummy drug)and fulvestrant. Women who took palbocicillin and fulvestrant lived for an average of 11.2 months, while women who took placebo and fulvestrant lived for an average of 4.6 months without worsening of their disease.

The second study involved666 women who had gone through menopause, whose breast cancer had begun to spread and who had not yet received cancer treatment. They received either palbocicillin and letrozole (an aromatase inhibitor) or placebo and letrozole. Women who took palbocicillin and letrozole lived on average 24.8 months without disease progression, while women who took placebo and letrozole lived on average 14.5 months. Original drugs in Hong Kong cost around 1 million, while generic drugs cost around 7more than 7more than 4 more than 1,000 per box. If you want to get more quality information, you can contact YaoDe, Yao De will do its best to learn more about high-quality overseas drugs for you.